Cargando…

Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution

Papillary renal cell carcinoma (pRCC) is an important subtype of kidney cancer with a problematic pathological classification and highly variable clinical behaviour. Here we sequence the genomes or exomes of 31 pRCCs, and in four tumours, multi-region sequencing is undertaken. We identify BAP1, SETD...

Descripción completa

Detalles Bibliográficos
Autores principales: Kovac, Michal, Navas, Carolina, Horswell, Stuart, Salm, Max, Bardella, Chiara, Rowan, Andrew, Stares, Mark, Castro-Giner, Francesc, Fisher, Rosalie, de Bruin, Elza C., Kovacova, Monika, Gorman, Maggie, Makino, Seiko, Williams, Jennet, Jaeger, Emma, Jones, Angela, Howarth, Kimberley, Larkin, James, Pickering, Lisa, Gore, Martin, Nicol, David L., Hazell, Steven, Stamp, Gordon, O’Brien, Tim, Challacombe, Ben, Matthews, Nik, Phillimore, Benjamin, Begum, Sharmin, Rabinowitz, Adam, Varela, Ignacio, Chandra, Ashish, Horsfield, Catherine, Polson, Alexander, Tran, Maxine, Bhatt, Rupesh, Terracciano, Luigi, Eppenberger-Castori, Serenella, Protheroe, Andrew, Maher, Eamonn, El Bahrawy, Mona, Fleming, Stewart, Ratcliffe, Peter, Heinimann, Karl, Swanton, Charles, Tomlinson, Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Pub. Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383019/
https://www.ncbi.nlm.nih.gov/pubmed/25790038
http://dx.doi.org/10.1038/ncomms7336
_version_ 1782364665019367424
author Kovac, Michal
Navas, Carolina
Horswell, Stuart
Salm, Max
Bardella, Chiara
Rowan, Andrew
Stares, Mark
Castro-Giner, Francesc
Fisher, Rosalie
de Bruin, Elza C.
Kovacova, Monika
Gorman, Maggie
Makino, Seiko
Williams, Jennet
Jaeger, Emma
Jones, Angela
Howarth, Kimberley
Larkin, James
Pickering, Lisa
Gore, Martin
Nicol, David L.
Hazell, Steven
Stamp, Gordon
O’Brien, Tim
Challacombe, Ben
Matthews, Nik
Phillimore, Benjamin
Begum, Sharmin
Rabinowitz, Adam
Varela, Ignacio
Chandra, Ashish
Horsfield, Catherine
Polson, Alexander
Tran, Maxine
Bhatt, Rupesh
Terracciano, Luigi
Eppenberger-Castori, Serenella
Protheroe, Andrew
Maher, Eamonn
El Bahrawy, Mona
Fleming, Stewart
Ratcliffe, Peter
Heinimann, Karl
Swanton, Charles
Tomlinson, Ian
author_facet Kovac, Michal
Navas, Carolina
Horswell, Stuart
Salm, Max
Bardella, Chiara
Rowan, Andrew
Stares, Mark
Castro-Giner, Francesc
Fisher, Rosalie
de Bruin, Elza C.
Kovacova, Monika
Gorman, Maggie
Makino, Seiko
Williams, Jennet
Jaeger, Emma
Jones, Angela
Howarth, Kimberley
Larkin, James
Pickering, Lisa
Gore, Martin
Nicol, David L.
Hazell, Steven
Stamp, Gordon
O’Brien, Tim
Challacombe, Ben
Matthews, Nik
Phillimore, Benjamin
Begum, Sharmin
Rabinowitz, Adam
Varela, Ignacio
Chandra, Ashish
Horsfield, Catherine
Polson, Alexander
Tran, Maxine
Bhatt, Rupesh
Terracciano, Luigi
Eppenberger-Castori, Serenella
Protheroe, Andrew
Maher, Eamonn
El Bahrawy, Mona
Fleming, Stewart
Ratcliffe, Peter
Heinimann, Karl
Swanton, Charles
Tomlinson, Ian
author_sort Kovac, Michal
collection PubMed
description Papillary renal cell carcinoma (pRCC) is an important subtype of kidney cancer with a problematic pathological classification and highly variable clinical behaviour. Here we sequence the genomes or exomes of 31 pRCCs, and in four tumours, multi-region sequencing is undertaken. We identify BAP1, SETD2, ARID2 and Nrf2 pathway genes (KEAP1, NHE2L2 and CUL3) as probable drivers, together with at least eight other possible drivers. However, only ~10% of tumours harbour detectable pathogenic changes in any one driver gene, and where present, the mutations are often predicted to be present within cancer sub-clones. We specifically detect parallel evolution of multiple SETD2 mutations within different sub-regions of the same tumour. By contrast, large copy number gains of chromosomes 7, 12, 16 and 17 are usually early, monoclonal changes in pRCC evolution. The predominance of large copy number variants as the major drivers for pRCC highlights an unusual mode of tumorigenesis that may challenge precision medicine approaches.
format Online
Article
Text
id pubmed-4383019
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Pub. Group
record_format MEDLINE/PubMed
spelling pubmed-43830192015-04-07 Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution Kovac, Michal Navas, Carolina Horswell, Stuart Salm, Max Bardella, Chiara Rowan, Andrew Stares, Mark Castro-Giner, Francesc Fisher, Rosalie de Bruin, Elza C. Kovacova, Monika Gorman, Maggie Makino, Seiko Williams, Jennet Jaeger, Emma Jones, Angela Howarth, Kimberley Larkin, James Pickering, Lisa Gore, Martin Nicol, David L. Hazell, Steven Stamp, Gordon O’Brien, Tim Challacombe, Ben Matthews, Nik Phillimore, Benjamin Begum, Sharmin Rabinowitz, Adam Varela, Ignacio Chandra, Ashish Horsfield, Catherine Polson, Alexander Tran, Maxine Bhatt, Rupesh Terracciano, Luigi Eppenberger-Castori, Serenella Protheroe, Andrew Maher, Eamonn El Bahrawy, Mona Fleming, Stewart Ratcliffe, Peter Heinimann, Karl Swanton, Charles Tomlinson, Ian Nat Commun Article Papillary renal cell carcinoma (pRCC) is an important subtype of kidney cancer with a problematic pathological classification and highly variable clinical behaviour. Here we sequence the genomes or exomes of 31 pRCCs, and in four tumours, multi-region sequencing is undertaken. We identify BAP1, SETD2, ARID2 and Nrf2 pathway genes (KEAP1, NHE2L2 and CUL3) as probable drivers, together with at least eight other possible drivers. However, only ~10% of tumours harbour detectable pathogenic changes in any one driver gene, and where present, the mutations are often predicted to be present within cancer sub-clones. We specifically detect parallel evolution of multiple SETD2 mutations within different sub-regions of the same tumour. By contrast, large copy number gains of chromosomes 7, 12, 16 and 17 are usually early, monoclonal changes in pRCC evolution. The predominance of large copy number variants as the major drivers for pRCC highlights an unusual mode of tumorigenesis that may challenge precision medicine approaches. Nature Pub. Group 2015-03-19 /pmc/articles/PMC4383019/ /pubmed/25790038 http://dx.doi.org/10.1038/ncomms7336 Text en Copyright © 2015, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Kovac, Michal
Navas, Carolina
Horswell, Stuart
Salm, Max
Bardella, Chiara
Rowan, Andrew
Stares, Mark
Castro-Giner, Francesc
Fisher, Rosalie
de Bruin, Elza C.
Kovacova, Monika
Gorman, Maggie
Makino, Seiko
Williams, Jennet
Jaeger, Emma
Jones, Angela
Howarth, Kimberley
Larkin, James
Pickering, Lisa
Gore, Martin
Nicol, David L.
Hazell, Steven
Stamp, Gordon
O’Brien, Tim
Challacombe, Ben
Matthews, Nik
Phillimore, Benjamin
Begum, Sharmin
Rabinowitz, Adam
Varela, Ignacio
Chandra, Ashish
Horsfield, Catherine
Polson, Alexander
Tran, Maxine
Bhatt, Rupesh
Terracciano, Luigi
Eppenberger-Castori, Serenella
Protheroe, Andrew
Maher, Eamonn
El Bahrawy, Mona
Fleming, Stewart
Ratcliffe, Peter
Heinimann, Karl
Swanton, Charles
Tomlinson, Ian
Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution
title Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution
title_full Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution
title_fullStr Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution
title_full_unstemmed Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution
title_short Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution
title_sort recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383019/
https://www.ncbi.nlm.nih.gov/pubmed/25790038
http://dx.doi.org/10.1038/ncomms7336
work_keys_str_mv AT kovacmichal recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT navascarolina recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT horswellstuart recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT salmmax recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT bardellachiara recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT rowanandrew recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT staresmark recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT castroginerfrancesc recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT fisherrosalie recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT debruinelzac recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT kovacovamonika recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT gormanmaggie recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT makinoseiko recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT williamsjennet recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT jaegeremma recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT jonesangela recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT howarthkimberley recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT larkinjames recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT pickeringlisa recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT goremartin recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT nicoldavidl recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT hazellsteven recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT stampgordon recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT obrientim recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT challacombeben recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT matthewsnik recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT phillimorebenjamin recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT begumsharmin recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT rabinowitzadam recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT varelaignacio recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT chandraashish recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT horsfieldcatherine recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT polsonalexander recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT tranmaxine recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT bhattrupesh recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT terraccianoluigi recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT eppenbergercastoriserenella recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT protheroeandrew recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT mahereamonn recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT elbahrawymona recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT flemingstewart recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT ratcliffepeter recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT heinimannkarl recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT swantoncharles recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution
AT tomlinsonian recurrentchromosomalgainsandheterogeneousdrivermutationscharacterisepapillaryrenalcancerevolution